Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print RSS Feed

Breaking News

Related Searches:
May 19, 2010
Chiltern has established two new offices and launched operations in Australia and Singapore, which will serve as the hub for its operations in Southeast Asia.  Read More »
May 19, 2010
Millipore Corp. has moved its European BioPharma Services unit to new, expanded facilities located in Milton Park, near Didcot in Oxfordshire, England.  Read More »
May 19, 2010
Evotec AG has advanced a compound in its strategic alliance with Boehringer Ingelheim into Phase I clinical studies.  Read More »
May 19, 2010
Quintiles and Kaiser Permanente’s Southern California Permanente Medical Group (SCPMG) have entered an agreement aimed at accelerating the development of new and more effective medicines.  Read More »
May 18, 2010
Pfizer Global Manufacturing is restructuring its worldwide plant network in an effort to align its manufacturing and supply organization following the acquisition of Wyeth.  Read More »
May 18, 2010
Columbia Laboratories, Inc. has renewed its license and supply agreement with Merck Serono for Crinone (progesterone gel) for an additional five years.  Read More »
May 18, 2010
Michael E. Placke, Ph.D., DABT, has been named senior vice president and general manager at Ricerca’s Concord, OH, facility.   Read More »
May 18, 2010
Revotar Biopharmaceuticals achieved positive results in Phase IIa Ozone Study with Bimosiamose for COPD.   Read More »
May 17, 2010
Astellas Pharma and OSI Pharmaceuticals have entered into a merger agreement under which Astellas will acquire OSI for approximately $4.0 billion in cash.   Read More »
May 17, 2010
David Spaight has been appointed chief executive officer of WIL Research Co.   Read More »
May 17, 2010
NeoPharm, Inc.’s IL13-PE38QQR (IL13-PE) has been granted orphan drug designation by the FDA for the treatment of Idiopathic Pulmonary Fibrosis (IPF).  Read More »
May 14, 2010
Anthony S. Chilton, Ph.D., has been appointed president and chief executive officer of Bioanalytical Systems, Inc.  Read More »
May 14, 2010
Mikel Moyer, Ph.D., has been named vice president of Molecular Discovery at Epizyme, Inc.   Read More »
May 14, 2010
Neotropix began enrolling patients in a Phase II trial to assess the efficacy of the novel oncolytic virus, NTX-010, in patients with extensive stage small cell lung cancer (SCLC).  Read More »
May 13, 2010
PAREXEL International Corp. has opened offices in Chengdu and Guangzhou, China to support a broad range of clinical development and regulatory consulting services throughout the Asia/Pacific region.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On